Preparation and evaluation of a self-emulsifying drug delivery system of etoposide–phospholipid complex

References

• Shirazi FH, Bahrami G, Stewart DJ, Tomiak E, Delorme F, Noel D, . (2001). A rapid reversed phase high performance liquid chromatographic method for determination of etoposide (VP-16) in human plasma. J Pharm Biomed Anal, 25:353–6.
   PubMed Web of Science ®Google Scholar
• Burden DA, Kingma PS, Froelich-Ammon SJ, Bjornsti MA, Patchan MW, Thompson RB, . (1996). Topoisomerase II. Etoposide interactions direct the formation of drug-induced enzyme-DNA cleavage complexes. J Biol Chem, 271:29238–44.
   PubMed Web of Science ®Google Scholar
• Kaul S, Srinivas NR, Igwemezie LN, Barbhaiya RH. (1996). A pharmacodynamic evaluation of hematologic toxicity observed with etoposide phosphate in the treatment of cancer patients. Semin Oncol, 23:15–22.
   PubMed Web of Science ®Google Scholar
• Shah JC, Chen JR, Chow D. (1989). Preformulation study of etoposide: Identification of physicochemical characteristics responsible for the low and erratic oral bioavailability of etoposide. Pharm Res, 6:408–12.
   PubMed Web of Science ®Google Scholar
• Tao Y, Yao Y, Ding Y, Wang H. (2006). Preparation and evaluation of etoposide solid dispersions in vitro. Zhong Nan Yao Xue, 4:250–3.
   Google Scholar
• Yuan K, Cao D, Li M, Cao W. (2004). Preparation and bioavailability in vivo of etoposide soft capsules. Zhongguo Yi Yao Gong Ye Za Zhi, 35:279–81.
   Google Scholar
• Wu J, Chen D. (2001). Study on the physico-chemical properties of baicalin-phospholipid complex. Zhongguo Yao Xue Za Zhi, 36:173–7.
   Google Scholar
• Li Y, Pan WS, Chen SL, Xu HX, Yang DJ, Chan ASC. (2006). Pharmacokinetic, tissue distribution, and excretion of puerarin and puerarin-phospholipid complex in rats. Drug Dev Ind Pharm, 32:413–22.
   PubMed Web of Science ®Google Scholar
• Li Y, Pan WS, Chen SL, Yang DJ, Chen S, Xu HX. (2006). Studies on preparation of puerarin phytosomes and their solid dispersion. Zhongguo Yao Xue Za Zhi, 41:1162–7.
   Google Scholar
• Zhou J, Wu Z, Ping Q, Zhou H, Xu B. (2006). Preparation and physicochemical properties of Indirubin—phospholipid complex. Zhongguo Yi Yao Gong Ye Za Zhi, 37:394–7.
   Google Scholar
• Yue PF, Yuan HL, Xie H, Xiao XH. (2008). Preparation, characterization, and bioavailability of ursodeoxycholic acid–phospholipid complex in vivo. Drug Dev Ind Pharm, 34:708–18.
   PubMed Web of Science ®Google Scholar
• Morazzoni P, Magistretti MJ, Giachetti C, Zanolo G. (1992). Comparative bioavailability of silipide, a new flavanolignan complex in rats. Eur J Drug Metab Pharmacokinet, 17:39–44.
   PubMed Web of Science ®Google Scholar
• Morazzoni P, Montalbetti A, Malandrino S, Pifferi G. (1993). Comparative pharmacokinetics of silipide and silymarin in rats. Eur J Drug Metab Pharmacokinet, 18:289–97.
   PubMed Web of Science ®Google Scholar
• Barzaghi N, Crema F, Gatti G, Pifferi G, Perucca E. (1990). Pharmacokinetic studies on IdB 1016, a sylibinphosphatidylcholine complex, in healthy human subjects. Eur J Drug Metab Pharmacokinet, 15:333–8.
   PubMed Web of Science ®Google Scholar
• Morazzoni P, Magistretti MJ, Zanolo G, Poletti P. (1989). Comparative bioavailability of IdB 1016, a new flavanolignan complex in rats. Planta Medica, 55: 654
   Google Scholar
• Hauss DJ, Fogal SE, Ficorilli JV, Price CA, Roy T, Jayaraj AA, . (1998). Lipid−based delivery systems for improving the bioavailability and lymphatic transport of a poorlywater−soluble LTB4 inhibitor. J Pharm Sci, 87:164–9.
   PubMed Web of Science ®Google Scholar
• Dabros T, Yeung A, Masliyah J, Czarnecki J. (1999). Emulsification through area contraction. J Colloids Interface Sci, 210:222–4.
   PubMed Web of Science ®Google Scholar
• Gershanik T, Benita S. (2000). Self-dispersing lipid formulations for improving oral absorption of lipophilic drugs. Eur J Pharm Biopharm, 50:179–88.
   PubMed Web of Science ®Google Scholar
• Gershanik T, Haltne E, Lehr CM, Benita S. (2000). Charge-dependent interaction of self-emulsifying oil formulations with Caco-2 cell monolayers: Binding, effects on barrier function and cytotoxicity. Int J Pharm, 211:29–36.
   PubMed Web of Science ®Google Scholar
• Kommuru TR, Gurley B, Khan MA, Reddy IK. (2001). Self-emulsifying drug delivery systems (SEDDS) of coenzyme Q10: Formulation development and bioavailability assessment. Int J Pharm, 212:233–46.
   PubMed Web of Science ®Google Scholar
• Kang BK, Lee JS, Chon SK, Jeong SY, Yuk SH, Khang G, . (2004). Development of self-microemulsifying drug delivery systems (SMEDDS) for oral bioavailability enhancement of simvastatin in beagle dogs. Int J Pharm, 274:65–73.
   PubMed Web of Science ®Google Scholar
• Holm R, Porter CJH, Müllertz A, Kristensen HG, Charman WN. (2002). Structured triglyceride vehicles for oral delivery of halofantrine: Examination of intestinal lymphatic transport and bioavailability in conscious rats. Pharm Res, 19:1354–61.
   PubMed Web of Science ®Google Scholar
• O'Driscoll CM. (2002). Lipid-based formulations for intestinal lymphatic delivery. Eur J Pharm Sci, 15:405–15.
   PubMed Web of Science ®Google Scholar
• Cui ShX, Nie ShF, Li L, Wang ChG, Pan WS, Sun JP. (2009). Preparation and evaluation of self-microemulsifying drug delivery system containing vinpocetin. Drug Dev Ind Pharm, 35:603–11.
   PubMed Web of Science ®Google Scholar
• Gursoy RN, Benita S. (2004). Self-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilic drugs. Biomed Pharmacother, 58:173–82.
   PubMed Web of Science ®Google Scholar
• Wu ZB, Guo D, Chen JM. (2009). Study on preparation and physicochemical properties of etoposide-phospholipid complex. Zhongguo Yi Yao Za Zhi, 13:1250–6.
   Google Scholar
• Pouton CW. (1997). Formulation of self-emulsifying drug delivery systems. Adv Drug Deliv Rev, 25:47–58.
   Web of Science ®Google Scholar
• Zhang P, Liu Y, Feng N, Xu H. (2008). Preparation and evaluation of self-emulsifying drug delivery system of oridonin. Int J Pharm, 355:269–76.
   PubMed Web of Science ®Google Scholar
• Wu W, Wang Y, Oue L. (2006). Enhanced bioavailability of silymarin by self-microemulsifying drug delivery system. Eur J Pharm Biopharm, 63:288–94.
   PubMed Web of Science ®Google Scholar
• Kim HJ, Yoon KA, Hahn M, Park ES, Chi SC. (2000). Preparation and in vitro evaluation of self-microemulsifying drug delivery systems containing idebenone. Drug Dev Ind Pharm, 26(5):523–9.
   PubMed Web of Science ®Google Scholar
• Sengupta S, Tyagi P, Velpandian T, Gupta YK, Gupta SK. (2000). Etoposide encapsulated in positively charged liposomes: Pharmacokinetics in mice and formulation stability studies. Pharmacol Res, 42:459–64.
   PubMed Web of Science ®Google Scholar
• Giaeomelli S, Gallo D, Apollonio P, Ferlini C, Distefano M, Morazzoni P, . (2002). Silybin and its bioavailable phospholipid complex (IdB 1016) potentiate in vitro and in vivo the activity of cisplatin. Life Sci, 70(12):1447–59
   PubMed Web of Science ®Google Scholar
• Drew RH, Dodds Ashley E, Benjamin DK Jr, Davis RD, Palmer SM, Perfect JR. (2004). Comparative safety of amphotericin B lipid complex and amphoteriein B deoxycholate as aerosolized antifungal prophylaxis in lung-transplant recipients. Transplantation, 77(2):232–7
   PubMed Web of Science ®Google Scholar
• Hooshmand-Rad R, Chu A, Gotz V, Morris J, Batty S, Freifeld A. (2005). Use of amphotericin B lipid complex in elderly patients. J Infect, 50:277–87.
   PubMed Web of Science ®Google Scholar
• Bellmann R, Egger P, Djanani A, Wiedermann CJ. (2004). Pharmacokinetics of amphotericin B lipid complex in critically ill patients on continuous veno-venous haemofiltration. Int J Antimicrob Agents, 23:80–3.
   PubMed Web of Science ®Google Scholar
• Li A, Zhao L, Zhai G, Lou H, Du J. (2008). An investigation on formation mechanisms and preparation of curcumin phospholipid complex. Zhongguo Zhong Yao Za Zhi, 17:2112–7.
   Google Scholar
• Wang Q, Xie H, Cong L, Yue P, Yuan H. (2008). Preparation and physicochemical properties of ursodeoxycholic acid—phospholipid complex. Zhongguo Yi Yao Gong Ye Za Zhi, 4:269–72.
   Google Scholar
• Lu Y, Zhang Y, Yang Z, Tang X. (2008). Formulation of an intravenous emulsion loaded with a clarithromycin-phospholipid complex, its pharmacokinetics in rats. Int J Pharm, 366:160–9.
   PubMedGoogle Scholar
• Maiti K, Mukherjee K, Gantait A, Saha BP, Mukherjee PK. (2007). Curcumin-phospholipid complex: Preparation, therapeutic evaluation and pharmacokinetic study in rats. Int J Pharm, 330:155–63.
   PubMed Web of Science ®Google Scholar
• Xiao Y, Song Y, Chen Z, Ping Q. (2006). The preparation of silybin-phospholipid complex and the study on its pharmacokinetics in rats. Int J Pharm, 307:77–82.
   PubMed Web of Science ®Google Scholar
• Trotta M, Pattarino F, Grosa G. (1998). Formation of lecithin-based microemulsions containing n-alkanol phosphocholines. Int J Pharm, 174:253–9.
   Web of Science ®Google Scholar
• Khoo SM, Humberstone AJ, Porter CJH, Edwards GA, Charman WN. (1998). Formulation design and bioavailability assessment of lipidic self-emulsifying formulations of halofantrine. Int J Pharm, 167:155–64.
   Web of Science ®Google Scholar
• Charman SA, Charman WN, Rogge MC, Wilson TD, Dutko FJ, Pouton CW. (1992). Self-emulsifying drug delivery system: Formulation and biopharmaceutic evaluation of an investigational lipophilic compound. Pharm Res, 9:87–93.
   PubMed Web of Science ®Google Scholar
• Tarr BD, Yalkowsky SH. (1989). Enhanced intestinal absorption of cyclosporine in rats through the reduction of emulsion droplet size. Pharm Res, 6:40–3.
   PubMed Web of Science ®Google Scholar
• Sachs-Barrable K, Lee SD, Wasan EK, Thorntona SJ, Wasana KM. (2008). Enhancing drug absorption using lipids: A case study presenting the development and pharmacological evaluation of a novel lipid-based oral amphotericin B formulation for the treatment of systemic fungal infections. Adv Drug Deliv Rev, 60(6):692–701
   PubMed Web of Science ®Google Scholar
• Swenson ES, Curatolo WJ. (1992). Means to enhance penetration. Adv Drug Deliv Rev, 8:39–42.
   Web of Science ®Google Scholar
• Venkatesh G, Majid MIA, Mansor SM, Nair NK, Croft SL, Navaratnam V. (2010). In vitro and in vivo evaluation of self-microemulsifying drug delivery system of buparvaquone. Drug Dev Ind Pharm, 36(6):735–745.
   Google Scholar
• Attivi D, Ajana I, Astier A, Demore B, Gibaud S. (2010). Development of microemulsion of mitotane for improvement of oral bioavailability. Drug Dev Ind Pharm, 36(4):421–7.
   PubMed Web of Science ®Google Scholar
• Aungst BJ, Saitoh H, Burchman DL, Huang S-M, Mousa SA, Hussain MA. (1996). Enhancement of the intestinal absorption of peptides and nonpeptides. J Control Release, 41:19–31.
   Web of Science ®Google Scholar
• Lohikangas L, Wilen M, Einarsson M, Artursson P. (1994). Effects of a new lipid-based drug delivery system on the absorption of low molecular weight heparin (Fragmin) through monolayers of human intestinal epithelial Caco-2 cells and after rectal administration to rabbits. Eur J Pharm Sci, 1:297–305.
   Web of Science ®Google Scholar
• Xiong J, Guo JX, Huang LSh, Meng BY, Ping QN. (2008). The use of lipid-based formulations to increase the oral bioavailability of Panax Notoginseng Saponins following a single oral gavage to rats. Drug Dev Ind Pharm, 34:65–72.
   PubMed Web of Science ®Google Scholar
• Beskid G, Unowsky J, Behl CR, Siebelist J, Tossounian JL, McGarry CM, . (1988). Enteral, oral, and rectal absorption of ceftriaxone using glyceride enhancers. Chemotherapy, 34:77–84.
   PubMed Web of Science ®Google Scholar
• Constanitinides PP, Scalart JP, Lancaster C, Marcello J, Marks G, Ellens H, . (1994). Formulation and intestinal absorption enhancement evaluation of water-in-oil microemulsions incorporating medium-chain glycerides. Pharm Res, 11:1385–90.
   PubMed Web of Science ®Google Scholar
• Yeh P-Y, Berenson MM, Samowitz WS, Kova PK, Kopecek JI. (1995). Site-specific drug delivery and penetration enhancement in the gastrointestinal tract. J Control Release, 36:109–24.
   Web of Science ®Google Scholar